Why the study?
Does cardiopulmonary exercise testing provide prognostic and diagnostic value in patients with pulmonary arterial hypertension?
Population
Patients with pulmonary arterial hypertension (PAH) and subjects at increased risk of developing PAH
Design
Review
Authors
Loading...
May inform PAH prognosis and exercise evaluation; leaves open prospective trials before guiding therapy.
Does cardiopulmonary exercise testing provide prognostic and diagnostic value in patients with pulmonary arterial hypertension?
Cardiopulmonary exercise testing is a valuable tool for the diagnosis, prognostic stratification, and therapeutic targeting of patients with pulmonary arterial hypertension.
Farina et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: